| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Emergency Medicine |
| Manuscript Type |
Case Control Study |
| Article Title |
Risk and predictors of severity and mortality in patients with type 2 diabetes and COVID-19 in Dubai
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Fatheya Alawadi, Alaaeldin Bashier, Azza Abdulaziz Bin Hussain, Nada Al-Hashmi, Fawzi Al Tayb Bachet, Mohamed Mahmoud Aly Hassanein, Marwan Abdelrahim Zidan, Rania Soued, Amar Hassan Khamis, Debasmita Mukhopadhyay, Fatima Abdul, Aya Osama, Fatima Sulaiman, Muhammad Hamed Farooqi and Riad Abdel Latif Bayoumi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Riad Abdel Latif Bayoumi, MBBS, PhD, Professor, asic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, Dubai , United Arab Emirates. riad.bayoumi@mbru.ac.ae |
| Key Words |
Type 2 diabetes; COVID-19; Risk factors; Mortality; United Arab Emirates |
| Core Tip |
Globally, patients with diabetes suffer from increased disease severity and mortality due to coronavirus disease 2019 (COVID-19). Old age, high body mass index (BMI), comorbidities, and complications of diabetes were recognized as major risk factors for infection severity and mortality. To identify the independent predictors of mortality in patients with type 2 diabetes (T2D) in Dubai, United Arab Emirates, we performed a cross-sectional nested case-control study during the first wave of the pandemic. It seems that the mortality of patients with T2D is driven by a significantly higher pro-inflammatory response to COVID-19 as evidenced by higher C-reactive protein, white blood cell, and lymphopenia. Mortality also seems to be synergistic with the comorbidities and complications of T2D in patients with COVID-19. The identified mortality predictors will help healthcare workers prioritize the management of patients with COVID-19. |
| Publish Date |
2023-08-11 11:04 |
| Citation |
Alawadi F, Bashier A, Bin Hussain AA, Al-Hashmi N, Bachet FAT, Hassanein MMA, Zidan MA, Soued R, Khamis AH, Mukhopadhyay D, Abdul F, Osama A, Sulaiman F, Farooqi MH, Bayoumi RAL. Risk and predictors of severity and mortality in patients with type 2 diabetes and COVID-19 in Dubai. World J Diabetes 2023; 14(8): 1259-1270 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i8/1259.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i8.1259 |
